Last reviewed · How we verify
NCT04943458
Application of Innovative Non-Invasive Neuroprotective Technology in Cardiac Surgery and Ophthalmology
trial testing Monitoring of cerebral autoregulation in Postoperative Cognitive Disorder in 270 participants. Status unknown.
1 July 2022
Quick facts
| Lead sponsor | Milda Svagzdiene |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 270 |
| Start date | 1 September 2021 |
| Primary completion | 1 July 2022 |
| Estimated completion | 1 October 2022 |
| Sites | 1 location across Lithuania |
Drugs / interventions tested
- Monitoring of cerebral autoregulation
Conditions studied
- Postoperative Cognitive Disorder — all drugs for Postoperative Cognitive Disorder →
- Glaucoma — all drugs for Glaucoma →
Sponsor
Milda Svagzdiene
Who can join
Adults 18 to 99, any sex, with Postoperative Cognitive Disorder or Glaucoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Postoperative cognitive dysfunction (POCD) and delirium (incidence up to 42 %) after cardiac surgery with cardiopulmonary bypass (CPB) are common postoperative complications that impair the patient's quality of life and increase the risk of death. Our previous studies confirm that postoperative POCD are associated with impaired cerebral autoregulation (CA) and momentary increased intracranial pressure (ICP) during surgery. The upper and lower limits of CA are individual and variable. In the elderly, CA is already partially impaired due to decreased cerebral vascular elasticity. What should be the optimal mean arterial pressure for each of these patients individually is not known. In order to individualize the boundaries of CA and prevent postoperative neurological complications, it would be ideal to objectify the condition of cerebral blood vessels. Direct studies of cerebrovascular and vascular status (CT angiography) are invasive and complex, and are therefore not routinely performed prior to cardiac surgery. However, cerebral blood flow and vascular condition can be assessed by retinal blood vessels, which can be considered as a direct biomarker of cerebrovascular disorders and can be visualized by ophthalmoscopy and objectively assessed by optical coherent tomography with angiography. In this biomedical study, individual patient CA will be monitored in a non-invasive manner during cardiac surgery with CPB. These data would allow real-time adjustments to physiological parameters while keeping them within normal limits. This is expected to reduce the risk of CA impairment and reduce the incidence of neurological complications following such surgery. Glaucoma is one of the leading causes of irreversible blindness in the world. As the population ages, the number of people with glaucoma increases as the prevalence of glaucoma increases with age. Recently, the influence of ICP on glaucoma optic neuropathy has been highlighted. It is thought that the pressure difference in the optic nerve area may be related to damage to the axons of the ganglion cells passing through the porous plate. Noninvasive ICP measurement is useful in explaining the pathophysiology of glaucoma, assessing translaminar pressure differentials, and seeking new guidelines for the treatment and prevention of glaucoma. Retinal blood flow, like cerebral blood flow, is autoregulated, autoregulation is maintained only within certain limits of perfusion pressure. Decreased ocular perfusion pressure impairs retinal autoregulation and may lead to the development or progression of glaucoma neuropathy. And the activity of neurons in the brain and retina causes local changes in blood circulation. Disruption of this neurovascular interaction during glaucoma neuropathy has not been adequately studied.The introduction of modern technologies into clinical practice enables the qualitative and quantitative assessment of autoregulatory disorders and the selection of optimal treatment.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Poster abstracts
· 2023 -
Delirium after coronary artery bypass grafting with cardiopulmonary bypass surgery: The value of cerebral autoregulation.
Kasputytė G, Kumpaitienė B, Švagždienė M, Andrejaitiene J, et al · · 2026 · PMID 40820307 · DOI 10.1177/02676591251370076 -
The Association of Cerebral Autoregulation Dysfunction and Postoperative Memory Impairment in Cardiac Surgery Patients.
Kasputytė G, Kumpaitienė B, Švagždienė M, Andrejaitienė J, et al · · 2024 · PMID 39202618 · DOI 10.3390/medicina60081337 -
Cardiac Surgery Patients Have Reduced Vascularity and Structural Defects of the Retina Similar to Persons with Open-Angle Glaucoma.
Vičaitė G, Barišauskaitė L, Bakstytė V, Siesky B, et al · · 2024 · PMID 38472987 · DOI 10.3390/diagnostics14050515
Verify or expand the search:
- PubMed search for NCT04943458
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04943458 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Milda Svagzdiene
- Last refreshed: 5 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04943458.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing